Cargando…
Selective inhibition of prostacyclin synthase activity by rofecoxib
The development of cyclooxygenase-2 (COX-2) selective inhibitors prompted studies aimed at treating chronic inflammatory diseases and cancer by using this new generation of drugs.Yet, several recent reports pointed out that long-term treatment of patients with COX-2 selective inhibitors (especially...
Autores principales: | Griffoni, Cristiana, Spisni, Enzo, Strillacci, Antonio, Toni, Mattia, Bachschmid, Markus Michael, Tomasi, Vittorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822831/ https://www.ncbi.nlm.nih.gov/pubmed/17488481 http://dx.doi.org/10.1111/j.1582-4934.2007.00021.x |
Ejemplares similares
-
RNAi-Based Strategies for Cyclooxygenase-2 Inhibition in Cancer
por: Strillacci, Antonio, et al.
Publicado: (2010) -
Cellular Prion Protein and Caveolin-1 Interaction in a Neuronal
Cell Line Precedes Fyn/Erk 1/2 Signal Transduction
por: Toni, Mattia, et al.
Publicado: (2006) -
RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cells
por: Strillacci, A, et al.
Publicado: (2006) -
Hypoxia–Reoxygenation Triggers Coronary Vasospasm in Isolated Bovine Coronary Arteries via Tyrosine Nitration of Prostacyclin Synthase
por: Zou, Ming-Hui, et al.
Publicado: (1999) -
Selective cyclooxygenase-2 silencing mediated by engineered E. coli and RNA interference induces anti-tumour effects in human colon cancer cells
por: Strillacci, A, et al.
Publicado: (2010)